CINECA IRIS Institutional Research Information System

MONTRUCCHIO, Giorgia Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.770
EU - Europa 1.888
AS - Asia 1.573
SA - Sud America 243
AF - Africa 45
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.736
IT - Italia 884
SG - Singapore 874
CN - Cina 397
IE - Irlanda 228
BR - Brasile 219
SE - Svezia 125
DE - Germania 124
FI - Finlandia 97
NL - Olanda 78
UA - Ucraina 78
HK - Hong Kong 73
FR - Francia 64
GB - Regno Unito 53
VN - Vietnam 49
AT - Austria 46
ID - Indonesia 37
IN - India 29
KR - Corea 24
CA - Canada 22
RU - Federazione Russa 20
BE - Belgio 19
PL - Polonia 18
TW - Taiwan 12
ES - Italia 10
LY - Libia 10
NG - Nigeria 10
EG - Egitto 8
PK - Pakistan 8
AU - Australia 7
CH - Svizzera 7
KE - Kenya 7
BD - Bangladesh 6
CO - Colombia 6
GR - Grecia 6
JP - Giappone 6
TR - Turchia 6
EC - Ecuador 5
IR - Iran 5
SA - Arabia Saudita 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
LT - Lituania 4
NP - Nepal 4
PE - Perù 4
UZ - Uzbekistan 4
EU - Europa 3
LB - Libano 3
MX - Messico 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
ZA - Sudafrica 3
AR - Argentina 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
IL - Israele 2
JO - Giordania 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 6.532
Salva come PNG Salva come JPEG
Città #
Santa Clara 491
Chandler 468
Singapore 443
Dublin 225
Turin 180
Ashburn 130
Fairfield 114
Columbus 94
Beijing 71
Nyköping 71
Hefei 68
Milan 66
Torino 66
Hong Kong 62
Medford 62
Princeton 50
Palermo 47
Cambridge 46
Agliè 41
Munich 41
Houston 40
Jakarta 37
Hangzhou 35
Wilmington 34
Helsinki 32
Lappeenranta 32
Seattle 32
Vienna 30
Ann Arbor 27
Nuremberg 26
Hebei 21
Woodbridge 20
Rome 18
São Paulo 18
Nanjing 17
Seoul 17
Turku 17
Villeurbanne 17
Boardman 16
Brussels 16
Silver Spring 16
Dong Ket 14
Guangzhou 14
Boston 13
Naples 13
Dearborn 12
New York 12
Los Angeles 11
Pune 11
Abuja 10
Belo Horizonte 10
Grugliasco 10
The Dalles 10
London 9
Redwood City 9
San Diego 9
Warsaw 9
Washington 9
Jacksonville 8
Pisa 8
Rivoli 8
Tripoli 8
Amsterdam 7
Brasília 7
Falls Church 7
Florence 7
Phoenix 7
Piemonte 7
San Francisco 7
Toronto 7
Trento 7
Upper Marlboro 7
Brooklyn 6
Curitiba 6
Guiyang 6
Jinan 6
Montreal 6
Norwalk 6
Redmond 6
Rio de Janeiro 6
Shanghai 6
Alessandria 5
Bialystok 5
Frankfurt am Main 5
Lauterbourg 5
Melbourne 5
Nairobi 5
Taipei 5
Wuhan 5
Baku 4
Berlin 4
Bologna 4
Chengdu 4
Chicago 4
Council Bluffs 4
Falkenstein 4
Fortaleza 4
Hanoi 4
Ho Chi Minh City 4
Ivrea 4
Totale 3.779
Salva come PNG Salva come JPEG
Nome #
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study 247
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation? 197
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis 191
ECMO for COVID-19 patients in Europe and Israel 150
IMPATTO DI UNA POLITICA DI “ANTIMICROBIAL STEWARDSHIP” SU CONSUMO DI ANTIBIOTICI E RESISTENZE BATTERICHE PRESSO L’A.O.U - POLICLINICO “SAN LUIGI GONZAGA”, TORINO 131
Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study 120
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms 119
Anaesthesia recommendations for Alport syndrome 119
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study 119
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball 116
ECMO Support and Operator Safety in the Context of COVID-19 Outbreak: A Regional Center Experience 115
First case of E. meningoseptica in Italy in a patient with necrotic hemorrhagic pancreatitis 113
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 113
Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis 102
Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units 102
Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation 98
Comparison of Copan UriSwab with BD ProbeTec urine preservative transport kit for preservation and detection of CT and NG in the ProbeTec assay 98
Choosing wisely: what's the actual role of antimicrobial stewardship in intensive care units? 98
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 97
Staphylococcus aureus producing Panton-Valentine Leukocidin: An emerging problem in Italian ICUs 92
Are other effects of Dexmedetomidine playing a role in explaining norepinephrine requirements decrease in septic shock patients? 89
Effects of steroids and tocilizumab on the immune response profile of patients with covid-19-associated ards requiring or not veno-venous extracorporeal membrane oxygenation 88
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements 88
Extracorporeal cardiopulmonary resuscitation (eCPR) 87
Antimicrobial Prophylaxis in ECMO: Is the Debate Still Open? 86
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design 83
Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach 80
Prognostic Value of Mid-Regional Proadrenomedullin Sampled at Presentation and after 72 Hours in Septic Patients Presenting to the Emergency Department: An Observational Two-Center Study 78
Oleander poisoning: an old toxic in the modern era 77
Extracorporeal Membrane Oxygenation for COVID-19 respiratory distress syndrome: an Italian Society for Cardiac Surgery Report 77
Beneficial Effect of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 75
Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study 75
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis 73
Prevalence and risk factors for Chlamydia trachomatis infection among female medical students and women attending family planning clinics in Northern Italy 72
The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience 71
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients from 29 Countries 67
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study 65
Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score 64
First Cases of Candida auris in a Referral Intensive Care Unit in Piedmont Region, Italy 64
A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold 63
Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key? 63
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 62
The use of Mid-Regional pro-Adrenomedullin as prognostic biomarker in ICU COVID-19 patients: preliminary data of Italian “second wave” of pandemic 62
Going beyond ECMO treatment activity of a regional referral center in the context of COVID 19 pandemic 62
Sugammadex-induced bronchospasm during desflurane anaesthesia: an open question 59
Is it time for a stewardship approach to vasopressors in refractory septic shock? 59
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial 58
Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study 57
Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with? 56
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19. 56
The value of open-source clinical science in pandemic response: lessons from ISARIC 54
Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN) 51
Epidemiology and Risk Factors for Nosocomial Infections in Left Ventricular Assist Device Recipients 50
Linfadenite da B. Henselae in paziente con pregressa infezione: reinfezione o riattivazione? 50
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series 49
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study 48
Are we at a turning point for disaster medicine education? The SIAARTI Academy Critical Emergency Medicine course experience 47
Tracheostomy timing and outcome in severe covid‐19: The weantrach multicenter study 47
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19 46
A letter to G.: When Words Are Not Enough (First Anniversary of Pandemic in the Words of a Doctor to a Patient) 46
Trichoderma spp.-Related Pneumonia: A Case Report in Heart–Lung Transplantation Recipient and a Systematic Literature Review 45
SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction? 45
Choice and management of vascular access in the context of COVID-19 outbreak in Italy: Recommendations from clinical practice 45
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin 45
Fourier Transform Infrared Spectroscopy Application for Candida auris Outbreak Typing in a Referral Intensive Care Unit: Phylogenetic Analysis and Clustering Cut-Off Definition 44
Variability of oxygen requirements in critically ill COVID-19 patients 44
Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic 44
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 43
Critical and non-critical coronavirus disease 2019 patients: which is the most predictive biomarker for disease severity and outcome? 42
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods 42
Norepinephrine may improve survival of septic shock patients in a low-resource setting: a proof-of-concept study on feasibility and efficacy outside the Intensive Care Unit 42
Efficacy and adverse events profile of videolaryngoscopy in critically ill patients: subanalysis of the INTUBE study 41
Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature 41
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort 41
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial 40
Skin microbiome and placement of vascular access: A solved problem? 40
Surgery at the time of COVID-19: let's go beyond the pandemic 40
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study 39
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19 39
null 39
Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation 39
Outcomes and Impact of Pre-ECMO Clinical Course in Severe COVID-19-Related ARDS Treated with VV-ECMO: Data from an Italian Referral ECMO Center 38
Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature 38
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission 36
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study 36
A multi-country analysis of COVID-19 hospitalizations by vaccination status 35
Oxygenation improvement and duration of prone positioning are associated with ICU mortality in mechanically ventilated COVID-19 patients 35
Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set 35
A noma case report: A warning message from Northern Uganda 35
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry 34
Multidrug-resistant pathogens and ventilator-associated pneumonia in critically ill COVID-19 and non-COVID-19 patients: a prospective observational monocentric comparative study 33
Gestione anestesiologica-rianimatoria del paziente COVID-19 33
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort 33
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study 32
Liver injury in hospitalized patients with COVID-19: An International observational cohort study 31
Providing background for antimicrobial stewardship strategy using costs data: a mission impossible? 26
Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 25
Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set 25
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study 24
Communication and visiting policies in Italian intensive care units during the first COVID-19 pandemic wave and lockdown: a nationwide survey 24
Totale 6.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.592
article - articoli 0
book - libri 0
conference - conferenze 1.960
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.552
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 17 9 20 9 23 12 9 19 20 47 74 94
2021/2022764 49 38 41 34 41 98 30 36 15 49 172 161
2022/20231.349 110 117 49 91 120 278 131 106 156 60 75 56
2023/2024802 75 109 41 39 40 89 33 42 20 72 80 162
2024/20253.054 57 192 133 220 561 281 189 148 351 219 260 443
2025/202670 70 0 0 0 0 0 0 0 0 0 0 0
Totale 6.876